Limitations, agreements, and source contact

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant · Source last updated 2018-06-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

CR_Study_Registration@mdanderson.org

organization

UT MD Anderson Cancer Center

phone

713-792-7734

title

Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice